Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 43353-124, Hydralazine Hydrochloride, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
43353-124
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA089098
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43353-124 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
43353-124-05433530124054200 TABLET in 1 BOTTLE (43353-124-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d9892176-d4a6-4edb-92b9-5f56243f3d22

Use it

Look up 43353-124 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43353-124 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43353-124. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.